Iroquois Capital Management LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-23 4:25 pm Purchase |
2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management LLC | 119,420 4.990% |
46,992 (+64.88%) |
Filing |
| 2021-10-22 06:51 am Purchase |
2021-10-18 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management LLC | 72,428 9.990% |
72,428 (New Position) |
Filing |